
UK variant looks set to cause a surge in global coronavirus cases
17 March 2021
Globally, since late February, coronavirus infections have started to rise again, mainly linked to the B.1.1.7 variant. The big question is what happens next

17 March 2021
Globally, since late February, coronavirus infections have started to rise again, mainly linked to the B.1.1.7 variant. The big question is what happens next

10 March 2021
The strategy of vaccinating the eldest first may save the most lives in the short term, but also has the greatest risk of creating variants that escape vaccine immunity

9 March 2021
Vaccination means freedom to mix in private properties without social distancing or wearing masks, US authorities have said, but the guidance is deemed too risky for the UK

1 March 2021
The P.1 variant from Brazil that has been detected in six people in the UK can partly evade existing antibodies, but vaccines should still protect against severe disease

26 February 2021
This is an archive of the 91av daily covid-19 news update with updates in February 2021. See updates from January 2021, November/December 2020, and March to November 2020.

23 February 2021
A new way of detecting the coronavirus could increase surveillance of dangerous mutations and alert individuals to which variant of the virus they are carrying

17 February 2021
A single genome sequence has shown that the UK and California variants of the coronavirus have combined into a heavily mutated hybrid. Here’s what you need to know about this recombinant variant of the coronavirus

17 February 2021
With news of one new variant after another, it's easy to despair that even vaccines won't be enough to overcome the coronavirus pandemic - but there are reasons to be optimistic

16 February 2021
The UK and California variants of coronavirus appear to have combined into a heavily mutated hybrid, sparking concern that we may be entering a new phase of the covid-19 pandemic

8 February 2021
South Africa has paused its roll-out of the Oxford/AstraZeneca vaccine because it might not be effective against the South African B.1.351 coronavirus variant – but it is still likely to limit the severity of covid-19